Stock CTNM CONTINEUM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Contineum Therapeutics, Inc.

Equities

CTNM

US21217B1008

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
15.32 USD +2.13% Intraday chart for Contineum Therapeutics, Inc. -2.79% -.--%
May. 20 Contineum Therapeutics, Inc. Appoints Troy Ignelzi as Independent Member of Its Board of Directors and as Chair of the Audit Committee CI
Apr. 30 Morgan Stanley Starts Contineum Therapeutics With Overweight Rating MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
BU
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
BU
Contineum Therapeutics Announces Pricing of Initial Public Offering
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTNM Stock
  4. News Contineum Therapeutics, Inc.
  5. Press Releases